NABRIVA THERAPEUTICS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NBRVF and buy or sell other stocks, ETFs, and their options commission-free!About NBRVF
Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the commercialization and development of novel anti-infective agents to treat infections. The company was founded in October 2005 and is headquartered in Dublin, Ireland.
CEOH. Michael Hogan
CEOH. Michael Hogan
Employees39
Employees39
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2017
Founded2017
Employees39
Employees39
NBRVF Key Statistics
Market cap646.17
Market cap646.17
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume109.70
Average volume109.70
High today$0.0002
High today$0.0002
Low today$0.0002
Low today$0.0002
Open price$0.0002
Open price$0.0002
Volume160.00
Volume160.00
52 Week high$0.0002
52 Week high$0.0002
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
NABRIVA THERAPEUTICS(NBRVF) stock is priced at $0.00, giving the company a market capitalization of 646.17.
On 2026-03-16, NABRIVA THERAPEUTICS(NBRVF) stock moved within a range of $0.00 to $0.00. With shares now at $0.00, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading volume for NABRIVA THERAPEUTICS(NBRVF) stock has reached 160, versus its average volume of 109.7.
The stock's 52-week range extends from a low of $0.00 to a high of $0.00.
The stock's 52-week range extends from a low of $0.00 to a high of $0.00.
People also own
Based on the portfolios of people who own NBRVF. This list is generated using Robinhood data, and it’s not a recommendation.